Randomized Study Using SM-030 Gel for Adults With Melasma

NCT06454747 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Melasma

Interventions

DRUG: SM-030 gel 0.64%
DRUG: Placebo gel
DRUG: SM-030 gel 0.08%

Sponsor

DermBiont, Inc.